John G Ullman & Associates Inc Quest Diagnostics Inc Transaction History
John G Ullman & Associates Inc
- $686 Million
- Q3 2025
A detailed history of John G Ullman & Associates Inc transactions in Quest Diagnostics Inc stock. As of the latest transaction made, John G Ullman & Associates Inc holds 1,114 shares of DGX stock, worth $152,718. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,114
Previous 1,114
-0.0%
Holding current value
$152,718
Previous $152,000
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
18 transactions
Others Institutions Holding DGX
# of Institutions
1,129Shares Held
105MCall Options Held
487KPut Options Held
534K-
Vanguard Group Inc Valley Forge, PA14.3MShares$1.95 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$1.38 Billion0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.01MShares$960 Million0.14% of portfolio
-
State Street Corp Boston, MA5.22MShares$716 Million0.03% of portfolio
-
Jpmorgan Chase & CO New York, NY4.32MShares$592 Million0.04% of portfolio
About QUEST DIAGNOSTICS INC
- Ticker DGX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 113,887,000
- Market Cap $15.6B
- Description
- Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...